Introduction to Semaglutide
Semaglutide is a synthetic peptide belonging to the class of glucagon-like peptide-1 (GLP-1) receptor agonists. Originally developed for metabolic research, it has become one of the most studied peptides in laboratory settings worldwide.
As a GLP-1 analogue, Semaglutide shares structural similarities with the naturally occurring incretin hormone GLP-1, which plays a key role in glucose homeostasis. Its modified structure provides enhanced stability and longer half-life compared to endogenous GLP-1.
Mechanism of Action
Semaglutide works by activating GLP-1 receptors, which are found in multiple tissues including the pancreas, brain, and gastrointestinal tract. In laboratory studies, this activation has been shown to influence insulin secretion patterns and glucose-dependent pathways.
Research has demonstrated that GLP-1 receptor agonism affects several metabolic parameters, including gastric emptying rate and energy intake regulation. These mechanisms make Semaglutide a valuable tool for studying metabolic pathways in controlled laboratory environments.
Laboratory Applications
Current research applications for Semaglutide include:
- Glucose metabolism studies
- Appetite regulation research
- Pancreatic beta cell function assays
- Energy expenditure investigations
At United Peptides, Semaglutide is available in 5mg vials, each batch independently tested via HPLC to verify ≥99% purity.